Search Results for 'cancer docetaxel'

cancer docetaxel published presentations and documents on DocSlides.

Docetaxel 100 Mg M2
Docetaxel 100 Mg M2
by stefany-barnette
docetaxel price usa. docetaxel injection ip monog...
NASPCC: Chemotherapy Options for Advanced Prostate Cancer
NASPCC: Chemotherapy Options for Advanced Prostate Cancer
by ceila
Jeanny B. Aragon-Ching, M.D., F.A.C.P.. Clinical P...
Please note, these are the actual video-recorded proceeding
Please note, these are the actual video-recorded proceeding
by cheryl-pisano
Moderator. Neil Love, MD. A Oliver Sartor, MD. Vi...
MEK Inhibitors and their potential role in relapsed NSCLC
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...
Second line
Second line
by alida-meadow
treatments. in WT . pts. : . which. . opportuni...
Thomas E. Keane
Thomas E. Keane
by danika-pritchard
Medical University of South Carolina . Charleston...
Thomas E. Keane  Medical University of South Carolina
Thomas E. Keane Medical University of South Carolina
by valerie
Charleston, SC. Bones, Hot Flashes, and ADT Use Wi...
Second line  treatments  in WT
Second line treatments in WT
by deena
pts. : . which. . opportunities. with . biologic...
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
by finley
Università . di Napoli “Federico II”. Innovat...
treating early breast cancer
treating early breast cancer
by calandra-battersby
Debbie Bajrovic. Oncology Pharmacist. Mount Hospi...
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
by marina-yarberry
Management of HER2 Over-Expressed Breast Cancer i...
Module 6:  Prostate Cancer
Module 6: Prostate Cancer
by payton
Victoria . Sinibaldi. , RN, MS, CS, CANP, BC. Dani...
6th Annual Interdisciplinary
6th Annual Interdisciplinary
by giovanna-bartolotta
Prostate Cancer . Congress. Meeting in . a. Box....
Best practice for chemotherapy for treatment of breast cancer
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Raising the Bar in the Management of Advanced/Metastatic NSCLC
Raising the Bar in the Management of Advanced/Metastatic NSCLC
by debby-jeon
Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...
What is the reference  cytotoxic
What is the reference cytotoxic
by pasty-toler
regimen in advanced gastric cancer?. Florian Lor...
Novel Biologic Therapies for
Novel Biologic Therapies for
by olivia-moreira
Second-Line Gastric Cancer. Charles S. Fuchs, MD....
Metastatic HER2-Positive Breast Cancer: Treatment Selection
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
New Therapies for Metastatic Breast Cancer
New Therapies for Metastatic Breast Cancer
by alexa-scheidler
Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...
New Ways of Managing Prostate Cancer
New Ways of Managing Prostate Cancer
by olivia-moreira
Jahangeer . M.Malik. Consultant Clinical Oncology...
ID DB06366 						 CATEGORY
ID DB06366 CATEGORY
by luanne-stotts
Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...
Matthew D. Galsky, MD Director, GU Medical Oncology
Matthew D. Galsky, MD Director, GU Medical Oncology
by luanne-stotts
Tisch. Cancer Institute. Icahn School of Medicin...
No F in FEC? Reduced Rates Of Severe Complications in EBC Chemotherapy
No F in FEC? Reduced Rates Of Severe Complications in EBC Chemotherapy
by christina
Marsden internal audit – FN 35% with FEC-T (19. ...
Paradigm Shift in the Management of  Metastatic Castration-Sensitive                 Prostate Cance
Paradigm Shift in the Management of Metastatic Castration-Sensitive Prostate Cance
by luna
m. CSPC). 1. Neal Shore, MD, FACS. Carolina Urolog...